Investigation on the Current Situation and Health-Related Quality of Life of Children and adolescents with OI in southwest China
暂无分享,去创建一个
[1] Victoria L Gremminger,et al. Impact of Intrinsic Muscle Weakness on Muscle–Bone Crosstalk in Osteogenesis Imperfecta , 2021, International journal of molecular sciences.
[2] I. Courtois,et al. The management of osteogenesis imperfecta in adults: state of the art. , 2019, Joint, bone, spine : revue du rhumatisme.
[3] J. Krischer,et al. Assessing disease experience across the life span for individuals with osteogenesis imperfecta: challenges and opportunities for patient-reported outcomes (PROs) measurement: a pilot study , 2019, Orphanet Journal of Rare Diseases.
[4] Y. Jiang,et al. Health-related quality of life in children with osteogenesis imperfecta: a large-sample study , 2019, Osteoporosis International.
[5] Erin C. Cobry,et al. Cyclic bisphosphonate therapy reduces pain and improves physical functioning in children with osteogenesis imperfecta , 2018, BMC Musculoskeletal Disorders.
[6] P. Fredriksen,et al. Peer relationships and quality of life in 11–12-year-old children: The Health Oriented Pedagogical Project (HOPP) , 2018, Scandinavian journal of public health.
[7] F. Rauch,et al. Pain and quality of life of children and adolescents with osteogenesis imperfecta over a bisphosphonate treatment cycle , 2018, European Journal of Pediatrics.
[8] L. Folkestad. Mortality and morbidity in patients with osteogenesis imperfecta in Denmark. , 2018, Danish medical journal.
[9] T. Félix,et al. Health-related quality of life of children and adolescents with osteogenesis imperfecta: a cross-sectional study using PedsQL™ , 2018, BMC Pediatrics.
[10] I. Mozoș,et al. Therapy with pamidronate in children with osteogenesis imperfecta , 2017, Drug design, development and therapy.
[11] J. Stinson,et al. Pain Experiences of Children and Adolescents With Osteogenesis Imperfecta: An Integrative Review , 2016, The Clinical journal of pain.
[12] M. Ford-Adams,et al. Weight loss surgery improves quality of life in pediatric patients with osteogenesis imperfecta. , 2017, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[13] E. Germain-Lee,et al. Cross-sectional and longitudinal growth patterns in osteogenesis imperfecta: implications for clinical care , 2016, Pediatric Research.
[14] F. Rauch,et al. Quality of life in osteogenesis imperfecta: A mixed‐methods systematic review , 2016, American journal of medical genetics. Part A.
[15] S. Walters,et al. Quality of life in children and adolescents with Osteogenesis Imperfecta: a qualitative interview based study , 2014, Health and Quality of Life Outcomes.
[16] C. Mehlman,et al. Diagnosis and Treatment of Osteopenic Fractures in Children , 2012, Current Osteoporosis Reports.
[17] X. Gu,et al. [Clinical study of oral alendronate in the treatment of pediatric osteogenesis imperfecta]. , 2012, Zhonghua yi xue za zhi.
[18] Hiroyuki Tanaka. Bisphosphonate treatment in osteogenesis imperfecta , 2012 .
[19] G. Pals,et al. Osteogenesis Imperfecta: A Review with Clinical Examples , 2011, Molecular Syndromology.
[20] Maria Helena Cabral de Almeida Cardoso,et al. Determinantes da marcha independente na osteogênese imperfeita , 2011 .
[21] P. Waber,et al. Impact of Alendronate on Quality of Life in Children With Osteogenesis Imperfecta , 2005, Journal of pediatric orthopedics.